bpc-157 subcutaneous or intramuscular Peptide BPC 157 (Body Protection Compound-157)
Description
They send signals to the brain
A 2025 narrative review of musculoskeletal research described both the regenerative findings and the open questions about translation to human clinical use (PMID 40789979)
Researchers study it for fat-cell shrinkage, higher NAD+ levels, and metabolic support without affecting appetite
Conveniently packaged in 5 x 2ml doses, this injection is perfect for both IM and IV use
some peptide reaches systemic circulation (supported by systemic effect reports) but at likely reduced bioavailability compared to parenteral
